OpenScience.ink

1 week ago • Advances in therapy

Who Uses Tirzepatide for Type 2 Diabetes in Germany and How They Are TreatedCharacteristics and Treatment Utilisation Patterns of Individuals Using Tirzepatide for Type 2 Diabetes in Germany.

📖 Top 20% JournalArticle

1 week ago • Medical sciences (Basel, Switzerland)

Skin Side Effects Linked to Semaglutide, Liraglutide, and TirzepatideCutaneous Adverse Events Associated with Semaglutide, Liraglutide and Tirzepatide: A Systematic Review.

🎖️ Top 10% JournalSystematic Review

1 week ago • Breast cancer research and treatment

Weight loss linked to GLP-1 receptor drugs in breast cancer patients receiving hormone therapyGLP-1 receptor agonist-associated weight loss in breast cancer patients receiving concurrent endocrine therapy: a retrospective cohort analysis.

🎖️ Top 10% JournalArticle

1 week ago • Diabetes, obesity & metabolism

Changes in Other Medication Use After Starting SemaglutideImpact of Semaglutide Introduction on the Use of Concomitant Medications: An Interrupted Time Series.

Article

1 week ago • Zhonghua wei chang wai ke za zhi = Chinese journal of gastrointestinal surgery

Safety and effectiveness of combining GLP-1 drugs with weight-loss surgery for obesity, based on treatment timing[Efficacy and safety of GLP-1 receptor agonists combined with bariatric surgery for obesity: a timing-stratified systematic review].

Systematic Review

1 week ago • Research square

Measuring how common and noticeable food-related background noise is among U.S. adultsFood noise among U.S. adults: Psychometric evaluation and prevalence estimates from a nationally representative sample.

Preprint

1 week ago • medRxiv : the preprint server for health sciences

Care Patterns After Starting Semaglutide or Tirzepatide and Their Links to Weight Loss in Obesity TreatmentPost-Initiation Care Patterns and Weight Loss With Semaglutide and Tirzepatide for Obesity in Clinical Practice.

Preprint

1 week ago • Frontiers in pharmacology

Tirzepatide compared to other diabetes treatments and the risk of lung flare-ups in people with type 2 diabetes and COPDTirzepatide versus other glucose-lowering therapies and risk of COPD exacerbations in patients with comorbid type 2 diabetes: a retrospective cohort study.

📖 Top 20% JournalArticle

1 week ago • bioRxiv : the preprint server for biology

Tirzepatide maintains blood stem cell activity and changes inflammatory immune cells in obese miceTirzepatide preserves hematopoietic stem and progenitor cycling while remodeling inflammatory monocytes in obese mice.

Preprint

1 week ago • Galen medical journal

Severe Stomach Movement Problems After a Single Dose of LiraglutideSevere Gastroparesis-like Syndrome Following Single-dose Liraglutide Administration: A Case Report : Short title: Severe Gastroparesis-like Syndrome Following Single-dose Liraglutide Administration.

Case Reports

1 week ago • Frontiers in endocrinology

GLP-1 receptor drugs and lymphedema: from weight loss to possible direct effects on lymph fluid drainageGLP-1 receptor agonists and lymphedema: from weight loss to potential direct modulation of lymphatic function.

🎖️ Top 10% JournalArticle

1 week ago • Cureus

Tirzepatide's effects on insulin-producing cell function in adults with type 2 diabetesEffects of Tirzepatide on Pancreatic β-Cell Function in Adults With Type 2 Diabetes Mellitus: A Systematic Review.

Article

1 week ago • Frontiers in medicine

Liraglutide's effects on blood pressure and kidney function in type 2 diabetes with kidney damageEffects of liraglutide on blood pressure and renal function in patients with type 2 diabetic nephropathy: a meta-analysis of randomized controlled trials.

📖 Top 20% JournalSystematic Review

1 week ago • International journal of preventive medicine

Recent Global Research Trends in Ozempic, Weight Loss, and PancreatitisVisualizing Emerging Trends and Global Hotspots in Ozempic, Weight Loss, and Pancreatitis Research: A Scientometric Analysis.

📖 Top 50% JournalArticle

1 week ago • Cureus

Muscle and Bone Side Effects Linked to Semaglutide, Liraglutide, and Tirzepatide in FDA ReportsMusculoskeletal Adverse Event Signals Associated With Semaglutide, Liraglutide, and Tirzepatide in the US FDA Adverse Event Reporting System.

Article

1 week ago • Cureus

Body Weight and Fat Changes with Standard versus Low Dose Tirzepatide in Women with LipedemaBody Composition Changes With Standard Versus Low-Dose Tirzepatide Titration in Women With Lipedema: A Retrospective Observational Study.

Article

1 week ago • medRxiv : the preprint server for health sciences

Use, Reasons, and Access to GLP-1 and GIP Treatments Among US AdultsGLP-1/GIP Uptake, Indication, and Access Pathways Among US Adults in the Understanding America Study.

Preprint

1 week ago • Frontiers in endocrinology

Periostin’s role, markers, and treatment possibilities in diabetic kidney diseasePeriostin in diabetic kidney disease: mechanistic insights, biomarkers, and therapeutic perspectives.

🎖️ Top 10% JournalArticle

1 week ago • Diabetes, obesity, and cardiometabolic CARE

How Adults with Obesity Stop, Restart, or Change Injectable Semaglutide and Tirzepatide TreatmentsPatterns of Prescription Discontinuation, Reinitiation, and Switching of Subcutaneous Semaglutide and Tirzepatide in Adults With Obesity.

Article

1 week ago • Open forum infectious diseases

How Long Semaglutide's Benefits Last After Stopping Treatment in Fat Buildup Linked to HIVDurability of Semaglutide Effects After Treatment Discontinuation in HIV-Associated Lipohypertrophy: A Randomized, Double-Blind, Placebo-Controlled Phase 2b Clinical Trial.

🎖️ Top 10% JournalClinical Trial

1 week ago • The British journal of psychiatry : the journal of mental science

Changes in metabolic markers before and after starting GLP-1 receptor treatment in people with schizophreniaMetabolic biomarker levels before and after initiation of GLP-1 receptor agonist treatment among individuals with schizophrenia: interrupted time-series analysis.

🥉 Top 5% JournalArticle

1 week ago • Journal of diabetes investigation

Poor Parasympathetic Function Measured by Deep Breathing Linked to Early Stopping of Oral Semaglutide in Type 2 DiabetesParasympathetic dysfunction assessed by deep-breathing CVR-R is associated with early discontinuation of oral semaglutide in type 2 diabetes: A multicenter retrospective study.

📖 Top 20% JournalArticle

1 week ago • Clinical nutrition ESPEN

Low sodium levels are linked to how patients with short bowel syndrome respond to glepaglutideSodium depletion is associated with the response to glepaglutide in short bowel syndrome with chronic intestinal failure.

📖 Top 30% JournalArticle

1 week ago • European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology

Effectiveness and safety of diabetes drugs for people with schizophrenia on antipsychotic treatmentEfficacy and safety of GLP-1 receptor agonists in patients with schizophrenia spectrum disorders treated with antipsychotics: a systematic review and meta-analysis.

🥉 Top 5% JournalArticle

1 week ago • Comprehensive physiology

Semaglutide changes the gut microbiome beyond reducing appetite with different gut-brain effects in males and femalesSemaglutide Remodels the Gut Microbiome Beyond Its Appetite-Suppressing Action: Sex-Specific Gut-Brain Axis Implications.

🎖️ Top 10% JournalArticle

1 week ago • European journal of clinical pharmacology

Effectiveness and safety of GLP-1 drugs for weight gain and metabolism problems linked to antipsychotic useEfficacy and safety of GLP-1 receptor agonists for antipsychotic-related overweight and metabolic dysregulation: a systematic review and meta-analysis.

📖 Top 20% JournalSystematic Review

1 week ago • Archives of osteoporosis

Effects of GLP-1 receptor therapy on bone health in adults with overweight or obesitySkeletal effects of GLP-1 receptor agonist therapy in adults with overweight or obesity: a systematic review.

📖 Top 20% JournalSystematic Review

1 week ago • ACS nano

Intestinal Immune Cells Package Peptides in Tiny Carriers to Create Long-Lasting Oral TreatmentsIntestinal Macrophage-Mediated Exosomal Repackaging Establishes Bioactive Reservoirs for Long-Acting Oral Peptide Therapy.

🥈 Top 2% JournalArticle

1 week ago • Journal of proteome research

Semaglutide and Tirzepatide reduce liver fat absorption and fat breakdown in obese mice fed a high-fat dietSemaglutide and Tirzepatide Suppress Hepatic Fatty Acid Uptake and Fatty Acid β-Oxidation in High-Fat Diet-Induced Obesity Mice.

📖 Top 20% JournalArticle

1 week ago • International journal of medical sciences

Link Between Using GLP-1 Medicines and Thyroid Health in Adults with Type 2 DiabetesAssociation of GLP-1 Receptor Agonist Use with Thyroid Outcomes in Adults with Type 2 Diabetes.

📖 Top 20% JournalArticle

← prevpage 6 of 16next →

Latest GLP-1 Therapies Research Papers